Ajooni Biotech Ltd Financials
Company Logo

Ajooni Biotech Ltd Financial Statement

Ajooni Biotech Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2024
Revenue25.70
Operating Expense24.70
Net Profit0.47
Net Profit Margin1.83
Earning Per Share0.03
EBIDTA0.99
Effective Tax Rate15.00

Ajooni Biotech Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Total Revenue Annual74.49
Operating Expenses Annual71.72
Operating Profit Annual3.06
Interest Annual0.48
Depreciation1.00
Net Profit Annual1.12
Tax Annual0.45

Ajooni Biotech Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Cash Flow at the Beginning0.06
Cash Flow from Operations-5.58
Cash Flow from Investing-15.82
Cash Flow from Financing21.66
Cash Flow at the End0.31

Ajooni Biotech Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
PBDIT Margin (%)4.11
PBIT Margin (%)2.77
PBT Margin (%)-2.96
Net PROFIT Margin (%)1.50
Return On Networth / Equity (%)3.86
Return On Networth /Employed (%)5.97
Return On Assets (%)3.26
Total Debt / Equity (X)0.18
Asset Turnover Ratio (%)2.17

Ajooni Biotech Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Fixed Assets Annual6.29
Total Current Assets Annual34.67
Non Current Assets Annual24.06
Total Shareholders Funds Annual41.67
Total Assets Annual58.73

Ajooni Biotech Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Sep 19, 2024, Ajooni Biotech Ltd has a market capitalization of 51.69 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Ajooni Biotech Ltd is debt-free with a debt-to-equity ratio of 0.05.
In FY 2023 , Ajooni Biotech Ltd recorded a total revenue of approximately 80.11 Cr marking a significant milestone in the company's financial performance.
Ajooni Biotech Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.9% and 0.0% annually, respectively..
Ajooni Biotech Ltd's current PE ratio is 23.93.
Ajooni Biotech Ltd's ROCE averaged 7.2% from the FY ending March 2022 to 2024, with a median of 7.9%. It peaked at 9.2% in March 2022, reflecting strong capital efficiency over the period..
Ajooni Biotech Ltd's latest EBIT is Rs. 3.56 Cr, surpassing the average EBIT of Rs. 2.54 Cr over the 5 years..